Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025

Group 1 - Jazz Pharmaceuticals plc will report its 2025 first quarter financial results on May 6, 2025, after the U.S. financial markets close [1] - A live audio webcast will be hosted by company management at 4:30 p.m. ET / 9:30 p.m. IST to discuss the financial results and provide a business update [1] - Interested parties can access the live audio webcast via the Investors section of the Jazz Pharmaceuticals website [2] Group 2 - Jazz Pharmaceuticals is a global biopharma company focused on developing life-changing medicines for serious diseases with limited therapeutic options [4] - The company has a diverse portfolio of marketed medicines, including therapies for sleep disorders, epilepsy, and a growing portfolio of cancer treatments [4] - Jazz Pharmaceuticals is headquartered in Dublin, Ireland, with research and development laboratories and manufacturing facilities in multiple countries [4]